Filing Details
- Accession Number:
- 0001753926-24-001578
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-16 16:56:55
- Reporting Period:
- 2024-09-12
- Accepted Time:
- 2024-09-16 16:56:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1919246 | Chromocell Therapeutics Corp | CHRO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1772168 | Richard Malamut | C/O Chromocell Therapeutics Corporation 4400 Route 9 South, Suite 1000 Freehold NJ 07728 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-12 | 10,400 | $0.94 | 91,565 | No | 4 | P | Indirect | Jointly held with spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Jointly held with spouse |
Footnotes
- This price represents the weighted average price of the shares purchased ranging from $0.9206 to $0.9554 per share, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
